Healthcare Infection Control Practices Advisory Committee (HICPAC), 3912 [2010-1275]

Download as PDF 3912 Federal Register / Vol. 75, No. 15 / Monday, January 25, 2010 / Notices Dated: January 14, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Dated: January 15, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC) . DEPARTMENT OF HOMELAND SECURITY [FR Doc. 2010–1274 Filed 1–22–10; 8:45 am] [FR Doc. 2010–1275 Filed 1–22–10; 8:45 am] [Docket ID: FEMA–2009–0001] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institutes of Health Healthcare Infection Control Practices Advisory Committee (HICPAC) jlentini on DSKJ8SOYB1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned committee: Times and Dates: 9 a.m.–5 p.m., February 11, 2010. 9 a.m.–12 p.m., February 12, 2010. Place: CDC, Global Communications Center, Building 19, Auditorium B3, 1600 Clifton Road, NE., Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: The Committee is charged with providing advice and guidance to the Secretary; the Assistant Secretary for Health; the Director, CDC; and the Director, National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID), regarding: (1) The practice of hospital infection control; (2) strategies for surveillance, prevention, and control of infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters To Be Discussed: The agenda will include updates on CDC healthcareassociated infections Recovery Act efforts; discussion on the draft guideline for prevention of intravascular catheter-related bloodstream infections; and the draft guideline for the prevention and management of norovirus gastroenteritis outbreaks in healthcare settings. Agenda items are subject to change as priorities dictate. For Further Information Contact: Michelle W. King, Committee Management Specialist, Division of Healthcare Quality Promotion, NCPDCID, CDC, 1600 Clifton Road, NE., Mailstop A–07, Atlanta, Georgia 30333, Telephone (404) 639–2936. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. VerDate Nov<24>2008 16:23 Jan 22, 2010 Jkt 220001 Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Molecular Mechanisms of Neurodegeneration. Date: January 27, 2010. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Lawrence Baizer, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4152, MSC 7850, Bethesda, MD 20892, (301) 435– 1257, baizerl@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: January 15, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–1225 Filed 1–22–10; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 Federal Emergency Management Agency Agency Information Collection Activities: Proposed Collection; Comment Request, 1660–0076; Hazard Mitigation Grant Program Application and Reporting AGENCY: Federal Emergency Management Agency, DHS. ACTION: Notice; 60-day notice and request for comments; revision of a currently approved information collection; OMB No. 1660–0076; No Form. SUMMARY: The Federal Emergency Management Agency, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take this opportunity to comment on a proposed revision of a currently approved information collection. In accordance with the Paperwork Reduction Act of 1995, this Notice seeks comments concerning the Hazard Mitigation Grant Program application and reporting requirements. DATES: Comments must be submitted on or before March 26, 2010. ADDRESSES: To avoid duplicate submissions to the docket, please use only one of the following means to submit comments: (1) Online. Submit comments at https://www.regulations.gov under docket ID FEMA–2009–0001. Follow the instructions for submitting comments. (2) Mail. Submit written comments to Office of Chief Counsel, Regulation and Policy Team, DHS/FEMA, 500 C Street, SW., Room 835, Washington, DC 20472– 3100. (3) Facsimile. Submit comments to (703) 483–2999. (4) E-mail. Submit comments to FEMA-POLICY@dhs.gov. Include docket ID FEMA–2009–0001 in the subject line. All submissions received must include the agency name and docket ID. Regardless of the method used for submitting comments or material, all submissions will be posted, without change, to the Federal eRulemaking Portal at https://www.regulations.gov, and will include any personal information you provide. Therefore, submitting this information makes it public. You may wish to read the Privacy Act notice that is available on the Privacy and Use Notice link on the Administration Navigation Bar of https:// www.regulations.gov. E:\FR\FM\25JAN1.SGM 25JAN1

Agencies

[Federal Register Volume 75, Number 15 (Monday, January 25, 2010)]
[Notices]
[Page 3912]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-1275]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting for the aforementioned 
committee:

    Times and Dates: 9 a.m.-5 p.m., February 11, 2010. 9 a.m.-12 
p.m., February 12, 2010.
    Place: CDC, Global Communications Center, Building 19, 
Auditorium B3, 1600 Clifton Road, NE., Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with providing advice and 
guidance to the Secretary; the Assistant Secretary for Health; the 
Director, CDC; and the Director, National Center for Preparedness, 
Detection, and Control of Infectious Diseases (NCPDCID), regarding: 
(1) The practice of hospital infection control; (2) strategies for 
surveillance, prevention, and control of infections (e.g., 
nosocomial infections), antimicrobial resistance, and related events 
in settings where healthcare is provided; and (3) periodic updating 
of guidelines and other policy statements regarding prevention of 
healthcare-associated infections and healthcare-related conditions.
    Matters To Be Discussed: The agenda will include updates on CDC 
healthcare-associated infections Recovery Act efforts; discussion on 
the draft guideline for prevention of intravascular catheter-related 
bloodstream infections; and the draft guideline for the prevention 
and management of norovirus gastroenteritis outbreaks in healthcare 
settings.
    Agenda items are subject to change as priorities dictate.
    For Further Information Contact: Michelle W. King, Committee 
Management Specialist, Division of Healthcare Quality Promotion, 
NCPDCID, CDC, 1600 Clifton Road, NE., Mailstop A-07, Atlanta, 
Georgia 30333, Telephone (404) 639-2936.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: January 15, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC) .
[FR Doc. 2010-1275 Filed 1-22-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.